Soft Tissue Sarcoma Adult Clinical Trial
Official title:
Evaluation of the Impact of Locoregional Treatment of Soft Tissue Sarcoma on the Functional Status of Patients Aged 70 Years and Over
In order to describe functional impact of surgery in elderly patients treated for lower-limb soft-tissue sarcoma, the investigators set up this project which aims to identify prognostic factors among geriatric and functional assessment.
This is a prospective cohort including 100 patients > 70 year-old treated by surgery for lower-limb soft-tissue sarcoma. Data on clinical and geriatric characteristics of the patient as well as functional and quality of life assessment will be collected among patient participation (3 years). Primary endpoint is to describe evaluation of the Impact of Locoregional Treatment of Soft Tissue Sarcoma on the Functional Status. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT04577014 -
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
|
Phase 1/Phase 2 | |
| Recruiting |
NCT04656262 -
Low Dose Continuous Cyclophosphamide vs Standard Doxorubicin in Advanced Sarcoma Elderly Patients
|
Phase 3 | |
| Not yet recruiting |
NCT06110650 -
A Study of Surufatinib in the Treatment of Advanced Soft Tissue Sarcoma
|
N/A | |
| Terminated |
NCT03735758 -
Quality of Life in Patients With Non-adipocyte Soft Tissue Sarcoma Under Palliative Chemotherapy or Pazopanib
|
Phase 4 | |
| Not yet recruiting |
NCT03951571 -
Efficacy and Safety of Anlotinib in Adjuvant Therapy for High-grade Soft Tissue Sarcoma
|
Phase 2 | |
| Enrolling by invitation |
NCT03134742 -
Radiation Effects on Bone
|
||
| Not yet recruiting |
NCT06252727 -
Fluorescent Aided Resection and Evaluation of Soft Tissue Sarcomas (FLARES)
|
Phase 1 | |
| Recruiting |
NCT04617327 -
Pre-operative RadiothErapy for Soft Tissue SarcOmas
|
N/A | |
| Recruiting |
NCT06385288 -
Blood and Tissue Extraction for Immunological Examinations During Neoadjuvant Therapy of Soft Tissue Sarcomas
|
N/A | |
| Recruiting |
NCT05116254 -
Sarcomas and DDR-Inhibition; a Combined Modality Study
|
Phase 1 | |
| Active, not recruiting |
NCT03526679 -
Lenvatinib and Eribulin in Advanced Soft Tissue Sarcoma
|
Phase 1/Phase 2 | |
| Recruiting |
NCT04008238 -
Prospective Identification of Predictive Biomarkers of Trabectedin Efficacy in Non-L Soft-tissue Sarcoma Patients
|
N/A | |
| Recruiting |
NCT04095208 -
Combination of Nivolumab Plus Relatlimab in Patients With Advanced or Metastatic Soft-tissue Sarcoma: a Proof-of-concept Randomized Phase II Study
|
Phase 2 | |
| Recruiting |
NCT04330456 -
Combined Treatment of Patients With Soft Tissue Sarcoma Including Preoperative Stereotactic Radiation Therapy and Postoperative Conformal Radiation Therapy
|
N/A | |
| Completed |
NCT03833037 -
Study of a Cohort of Cases of Synovial Sarcoma Treated in the Orthopedic Surgery and Traumatology Department of the Hospital de Sant Pau Between 1983 and 2016
|
||
| Completed |
NCT03056599 -
Precise Local Injection of Anti-cancer Drugs Using Presage's CIVO Device in Soft Tissue Sarcoma
|
Phase 1 | |
| Recruiting |
NCT05961761 -
Propranolol and Pembrolizumab in Advanced Soft Tissue Sarcoma Patients
|
Phase 2 | |
| Recruiting |
NCT06273852 -
A Study of the Intratumoral Microdose Administration of PBA-0405 in Patients With Solid Tumors
|
Early Phase 1 | |
| Recruiting |
NCT05182164 -
Combination of Pembrolizumab and Cabozantinib in Patients With Advanced Sarcomas
|
Phase 2 | |
| Withdrawn |
NCT03104335 -
Apatinib for Advanced Soft Tissue Sarcoma Patients: a Phase 2, Multicenter Trial
|
Phase 2 |